While little-known on Wall Street, Kennesaw, Georgia based CryoLife (CRY), a reputable name in the medical equipment sector, could soon win more attention from investors. The company is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S., Canada and some countries in Europe.
CryoLife is a cash-rich and debt-free company with a market cap of $176 million. As of March 31, 2013, CryoLife had 13.9 million in cash and cash equivalents on its book. Recently the company raised its quarterly cash dividend by 10% for the second quarter of 2013. The company's earnings are expected to increase substantially going forward. In this article...
Only subscribers can access this article, which is part of the PRO research library covering 3,574 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: